| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/17/1993 | EP0531640A1 Antibiotic LL-E19020 Gamma |
| 03/17/1993 | EP0531597A1 Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine |
| 03/17/1993 | EP0531452A1 Synthesis of glycerol di- and triphosphate derivatives |
| 03/17/1993 | EP0531447A1 Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna |
| 03/17/1993 | EP0531413A1 An antiviral composition containing prostratin |
| 03/17/1993 | EP0531369A1 1,4-dihydropyridines for application in combatting resistance to drugs |
| 03/17/1993 | EP0531365A1 Diagnosis and treatment of viral hepatitis |
| 03/17/1993 | CN1069976A Cyclohexan and tetrahydropyran derivatives |
| 03/17/1993 | CN1069882A Compounds and methods for inhibition of HIV and related viruses |
| 03/17/1993 | CN1020107C Process for antivirotic compound |
| 03/17/1993 | CN1020106C Process for pyrimidine derivatives |
| 03/16/1993 | US5194654 Viricides for retroviral infections such as aids |
| 03/16/1993 | US5194605 Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs |
| 03/16/1993 | US5194604 Reacting a novel substrate with a beta lactam and a base |
| 03/16/1993 | US5194586 Adult T Cell Leukemia Associated Antigen |
| 03/16/1993 | US5194581 Biodegradable poly(phosphoesters) |
| 03/16/1993 | US5194433 Improved effectiveness against resistant bacteria |
| 03/16/1993 | US5194428 Inhibition of influenza virus replication by oligonucleotide phosphorothioates |
| 03/16/1993 | US5194371 Production of pradimicin antibiotics |
| 03/16/1993 | CA1314544C 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinoline- carboxylic acids, processes for their preparation and antibacterial agents containing these compounds |
| 03/16/1993 | CA1314481C Liposomal preparation and antibiotic |
| 03/15/1993 | CA2078057A1 Substituted aminopropanes, processes for their preparation, and their use |
| 03/14/1993 | CA2078087A1 Hsv gd2 baculovirus expression system |
| 03/14/1993 | CA2077993A1 Oligosaccharide aromatic glycoside sulfate |
| 03/13/1993 | CA2078030A1 Unsaturated acyclic phosphonate derivatives of purine and pyrimidine |
| 03/13/1993 | CA2077948A1 Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents |
| 03/11/1993 | CA2077836A1 Process for the preparation of a cephalosporin antibiotic |
| 03/10/1993 | EP0531228A1 Thiourea derivatives, antimicrobial agent and antiulcer agent containing the same |
| 03/10/1993 | EP0531080A2 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene protein |
| 03/10/1993 | EP0531016A2 Polysulfate of beta-cyclodextrin derivative and process for preparing the same |
| 03/10/1993 | EP0530907A1 Indoles as inhibitors of HIV reverse transcriptase |
| 03/10/1993 | EP0530861A2 Topical antimicrobial pharmaceutical compositions |
| 03/10/1993 | EP0530614A1 Novel antisense oligonucleotider with continuous phosphoramidate internucleotide linkage |
| 03/10/1993 | EP0530407A1 Substituted, nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them |
| 03/10/1993 | EP0530355A1 Novel fluorine-containing quinolones and process for their preparation |
| 03/10/1993 | EP0530268A1 Process for the preparation of 7-alpha-alkoxycephem derivatives. |
| 03/10/1993 | EP0346460B1 Purine derivatives having pharmacological action |
| 03/10/1993 | CA2077611A1 Antibiotic ll-e19020 zeta and ll-e19020 eta |
| 03/10/1993 | CA2077583A1 Antibiotic ll-e19020 gamma |
| 03/09/1993 | US5192756 Aminosterol antibiotic |
| 03/09/1993 | US5192539 Infectious bursal disease virus production in continuous cell lines |
| 03/09/1993 | CA1314285C Pseudo-primycin complexes, components and acid addition salts thereof as well as a process for the preparation of same |
| 03/09/1993 | CA1314255C Antibiotic reuterin |
| 03/09/1993 | CA1314228C Naphthyridine antianaerobic compounds |
| 03/09/1993 | CA1314221C Antiinfective composition containing non-ionic surfactant |
| 03/07/1993 | CA2077283A1 Inhibitors of hiv reverse transcriptase |
| 03/07/1993 | CA2077122A1 Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same |
| 03/05/1993 | CA2077466A1 Substituted nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them |
| 03/05/1993 | CA2077322A1 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins |
| 03/04/1993 | WO1993004175A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 03/04/1993 | WO1993004085A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof |
| 03/04/1993 | WO1993004043A1 Anti-hiv (aids) agents |
| 03/04/1993 | WO1993003770A1 Method and compositions for cellular reprogramming |
| 03/04/1993 | WO1993003765A1 Escherichia coli o-polysaccharide-protein conjugate vaccine |
| 03/04/1993 | WO1993003764A1 Hla-restricted hepatitis b virus ctl epitopes |
| 03/04/1993 | WO1993003762A1 Immunostimulation |
| 03/04/1993 | WO1993003761A1 METHODS AND COMPOSITIONS RELATING TO USEFUL ANTIGENS OF $i(MORAXELLA CATARRHALIS) |
| 03/04/1993 | WO1993003760A1 Sirs vaccine and diagnosis method |
| 03/04/1993 | WO1993003753A1 Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus |
| 03/04/1993 | WO1993003708A1 Pharmaceutical aerosol preparation and its use for treatment and prophylaxis of viral diseases |
| 03/04/1993 | WO1993003668A1 Cardiac output probe assembly |
| 03/04/1993 | WO1992018123A3 A method for inhibition of retroviral replication |
| 03/04/1993 | CA2116359A1 Anti-hiv proteins gap 31, dap 30, and dap 32, dna coding therefor and therapeutic uses thereof |
| 03/04/1993 | CA2115581A1 Anti-hiv (aids) agents |
| 03/04/1993 | CA2115554A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 03/04/1993 | CA2115424A1 Immunostimulation |
| 03/04/1993 | CA2077314A1 Antisense oligonucleotides with phosphoramidate internucleotide linkage throughout |
| 03/03/1993 | EP0529976A1 1,3,2-Dioxathiolan-S-oxide derivatives, their use as fungicedes and as intermediates |
| 03/03/1993 | EP0529854A2 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-COA reductase inhibitors |
| 03/03/1993 | EP0529584A2 Viral agent associated with the Mystery Swine Disease |
| 03/03/1993 | EP0529410A2 Antibiotic GE 2270 factor C2a |
| 03/03/1993 | EP0529008A1 Modulation of gene expression through interference with rna secondary structure |
| 03/03/1993 | EP0528985A1 Cephalosporin esters which are useful as antibiotics |
| 03/03/1993 | EP0528951A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
| 03/03/1993 | EP0528861A1 Composition and treatment with biologically active peptides and toxic cations |
| 03/03/1993 | EP0528859A1 Oral vaccine comprising antigen surface-associated with red blood cells |
| 03/03/1993 | EP0495919A4 Protection from shock subsequent to injury by double-stranded rnas |
| 03/03/1993 | EP0419501B1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components |
| 03/03/1993 | EP0364442B1 Therapeutical compositions against psoriasis |
| 03/03/1993 | EP0211013B1 Immunotherapeutic methods and compositions employing antigenes characteristic of malignant neoplasms |
| 03/03/1993 | CN1069494A 1-methylcarbapenem derivatives, their preparation and their use as antibiotics |
| 03/03/1993 | CN1019977C Process for preparing metal complex of N-methyl-11-aza-10-deoxy-10-dihydroerythromycins A and 11-aza-10-deoxy-10-dihydroerythromycins A |
| 03/02/1993 | US5191093 Process for preparing crystalline calcium pseudomonate |
| 03/02/1993 | US5190961 Thiourea derivatives and antimicrobial agent and antulcer agent containing the same |
| 03/01/1993 | WO1993005152A1 Antibodies to streptolysin o derivatives and variants |
| 03/01/1993 | CA2094242A1 Antibodies to streptolysin o derivatives and variants |
| 02/27/1993 | CA2076903A1 Recombinant fowlpox virus |
| 02/24/1993 | EP0528767A1 Antibody derivatives |
| 02/24/1993 | EP0528678A1 A pyrrolidylthiocarbapenem derivative |
| 02/24/1993 | EP0528661A2 HIV protease inhibitors with N-terminal polyether substituents |
| 02/24/1993 | EP0528468A1 Use of triclosan for the manufacture of a medicament for inhibiting cyclooxygenase |
| 02/24/1993 | EP0528242A2 Trifluoromethyl containing pseudopeptides |
| 02/24/1993 | EP0528135A1 Uses of 9,12,15-octadecatrien-6-ynoic acid |
| 02/24/1993 | EP0527979A1 Pharmaceutical for treating viral diseases |
| 02/24/1993 | EP0527916A1 Antisense inhibitors of the human immunodeficiency virus |
| 02/24/1993 | EP0527906A1 Inhibition of influenza virus replication by oligonucleotides |
| 02/24/1993 | EP0527889A1 Quinolizinone type compounds |
| 02/24/1993 | EP0527832A1 Anti-fungal bile acid derivatives |
| 02/24/1993 | EP0527789A1 Hiv envelope polypeptides |
| 02/24/1993 | EP0527785A1 Improvements relating to the detection of viruses |